Main > ONCOLOGY (**) > Lung>NSCLC>MET>ALK+ *** > Treatment > CH. N. Ceritinib Cap.

---

CH. N. Ceritinib Cap.'s subsections
(*) EU Approvals>
(*) USA Approvals>>
Companion Diagnostics>
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2017. 05.30
TradeMark
TradeMark Web-Site

CH. N. Ceritinib Cap.'s products
This section has no products